Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -2.232% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a. C=C1C(C(=O)N2CCN(C)CC2)C1C(=O)N1CCN(C)CC1
b. CC1CCc2nc3ccc(S(=O)(=O)N4CCC(C(=O)NC(C)c5ccccc5)CC4)cc3c(C(=O)O)c2C1
c. Cc1ccccc1N(CC(=O)N/N=C/c1ccc(Cl)cc1)C(=O)c1ccccc1
d. O=P(c1ccccc1)(c1ccccc1)C(O)c1ccco1
Answer: a. C=C1C(C(=O)N2CCN(C)CC2)C1C(=O)N1CCN(C)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C=C1C(C(=O)N2CCN(C)CC2)C1C(=O)N1CCN(C)CC1
C=C1C(C(=O)N2CCN(C)CC2)C1C(=O)N1CCN(C)CC1
[2-methylidene-3-(4-methylpiperazine-1-carbonyl)cyclopropyl]-(4-methylpiperazin-1-yl)methanone